β2-Glycoprotein I as a 'cofactor' for anti-phospholipid reactivity with endothelial cells

Lupus

Volumn 7, Issue SUPPL. 2, 1998, Pages

  Meroni, P L ^a,f   Del Papa, N ^a   Raschi, E ^a   Panzeri, P ^a   Borghi, M O ^a   Tincani, A ^a   Balestrieri, G ^b   Khamashta, Ma ^c   Hughes, G R V ^c   Koike, T ^d   Krilis, S A ^e  

^a UNIVERSITY OF MILAN   (Italy)

^b SPEDALI CIVILI   (Italy)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d HOKKAIDO UNIVERSITY   (Japan)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f Padiglione Granelli   (Italy)

Author keywords

Anti phospholipid antibodies; Endothelial cells; Heparan sulphate; 2 glycoprotein I

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN; ENDOTHELIAL CELL GROWTH FACTOR; GLYCOPROTEIN; HEPARAN SULFATE; PHOSPHOLIPID ANTIBODY; SYNTHETIC PEPTIDE; ANION; AUTOANTIGEN; CARDIOLIPIN ANTIBODY; EPITOPE; PROTEOGLYCAN;

BINDING SITE; CELL ACTIVATION; CELL ADHESION; CELL MEMBRANE; CONFERENCE PAPER; ENDOTHELIUM CELL; GENE MUTATION; HUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; AMINO ACID SUBSTITUTION; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASE; BLOOD CLOTTING; CHEMISTRY; CYTOLOGY; GENETICS; IMMUNOLOGY; MACROMOLECULE; METABOLISM; PHYSIOLOGY; POINT MUTATION; PROTEIN BINDING; PROTEIN CONFORMATION; REVIEW; SURFACE PROPERTY; VASCULAR ENDOTHELIUM;

AMINO ACID SUBSTITUTION; ANIONS; ANTIBODIES, ANTICARDIOLIPIN; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIGENS; AUTOIMMUNE DISEASES; BETA 2-GLYCOPROTEIN I; BINDING SITES; BLOOD COAGULATION; CELL MEMBRANE; ENDOTHELIUM, VASCULAR; EPITOPES; GLYCOPROTEINS; HEPARITIN SULFATE; HUMANS; MACROMOLECULAR SUBSTANCES; POINT MUTATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEOGLYCANS; SURFACE PROPERTIES;

EID: 0032245795     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339800700211     Document Type: Conference Paper

References (47)

1. McNeil HP, Chesterman CN, Krilis SA Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 1991; 49; 193-280
2. Kandiah DA, Krilis SA. Immunology and methods of detection of antiphospholipid antibodies. In: Asherson RA, Cervera R, Piette JC, Shoenfeld Y (eds) The Antiphospholipid Syndrome CRC Press, Boca Raton, FL, 1996, pp 29-48.
3. McNeil H, Simpson RJ, Chesterman CN, Krilis SA Antiphospholipid antibodies arc directed against a complex antigen that includes a lipid-binding inhibitor of coagulation. β2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87: 4120-4124.
4. Galli M et al. Anticardiolipin antibodies (ACA) are directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990;335: 1544-1547.
5. Roubey RA Immunology of antiphospholipid antibody syndrome. Arthritis Rheum 1996, 39: 1444-1454.
6. Matsuura E et al. Anti-cardiolipin antibodies recognise β2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface J Exp Med 1994; 179: 457-462
7. Arvieux J, Roussel B, Jacob MC, Columb MG. Measurement of anti-phospholipid antibodies by ELISA using β2-glycoprotein I as antigen. J Immunol Methods 1991; 143: 223-229.
8. Viard JP, Amoura Z, Bach JF. Association of anti-β2-glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus Am J Med 1992; 93: 181-186.
9. Cabiedes J, Cabrai AR, Alarcon Segovia D. Clinical manifestations of anti-phospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-β2-glycoprotein I than with anti-phospholipid antibodies. J Rheumatol 1995; 22: 1899-1906
10. Balestrieri G et at. Anti-β2-glycoprotein I antibodies, a marker of the antiphospholipid syndrome. Lupus 1995; 4: 122-130.
11. Pengo V, Biastolo A, Fior MG. Autoimmune phospholipid antibodies are directed against cryptic epitope expressed when β2-glycoprotein I is bound to a suitable surface. Thromb Haemost 1995; 73: 29-34.
12. Martinuzzo ME, Forastiero RR, Carerras LO. Anti-β2-glycoprotein I antibodies: detection and association with thrombosis. Br J Haematol 1995, 89. 397-402.
13. Tincani et al. The anti-β2-glycoprotein I activity in human antiphospholipid syndrome sera is due to monoreactive low-affinity autoantibodies directed to epitopes located on native β2-glycoprotein I and preserved during species' evolution. J Immunol 1996; 157: 5732-5738.
14. Wurm H Beta 2 glycoprotein I (apolipoprotein H) interactions with phospholipid vesicles. Int J Biochem 1984; 16: 511-515
15. Polz E Isolation of a specific lipid-bindmg protein from human serum by affinity chromatography using heparm-Sepharose. In: Peeters H (ed.) Protides of Biological Fluids Pergamon Press: Oxford, 1979, p. 817
16. Kato H, Enjyoji K. Amino acid sequence and location of the disulfide bonds in bovine beta 2 glycoprotein I: the presence of five Sushi domains Biochemistry 1991; 30: 11687-11692.
17. Steinkasser A et al. Complete nucleotide and deduced amino acid sequence of human beta 2 glycoprotein I. Biochemical J 1991; 277: 387-391.
18. Matsuura E et al. Molecular studies on phospholipid-binding sites and cryptic epitopes appearing on β2-glycoprotein I structure recognized by anticardiolipin antibodies. Lupus 1995; 4: 513-517.
19. Hunt JE, Simpson RJ, Krilis SA. Identification of a region of β2-glycoprotein 1 critical for lipid binding and anti-cardiolipin antibody cofactor activity. Proc Natl Acad Sci USA 1993, 90: 2141-2145.
20. 288) and a region recognized by anti-cardiolipin antibodies. J Immunol 1994, 152: 653-659
21. Hagihara Y, Goto Y, Kisao H, Yoshimura T. Role of the N- and C-terminal domains of bovine β2-glycoprotein I in its interaction with cardiolipin. J Biochem (Tokyo) 1995; 118 129-136.
22. Sheng Y et al. Site-directed mutagenesis of recombinant human β2-glycoprotein I identifies a cluster of lysine residues that are critical for phospholipid binding and anti-cardiolipin antibody activity. J Immunol 1996, 157: 3744-3751.
23. Vazquez-Mellado J, Llorente L, Richaud-Patin Y, Alarcon-Segovia D. Exposure of anionic phospholipids upon platelet activation permits binding of β2-glycoprotein I and through it that of IgG antiphospholipid antibodies. Studies in platelets from patients with antiphospholipid syndrome and normal subjects. J Autoimmun 1994; 12: 122-131.
24. Shi W, Chong BH, Chesterman CN. β2-glycoprotein I is a requirement for anticardiolipin antibodies binding to activated platelets: differences with lupus anticoagulant. Blood 1993; 81: 1255-1262.
25. Casciola-Rosen L, Rosen A, Petri M, Schlissel M. Surface blebs on apoptotic cells are sites of enhanced procoagulant activity implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc Natl Acad Sci USA 1996, 93. 1624-1629.
26. Manfredi A et al Apoptotic cell clearance in systemic lupus erythematosus. I. Opsonization by antiphospholipid antibodies. Arthritis Rheum 1998; 40: 205-214.
27. Manfredi A et al Apoptotic cell clearance in systemic lupus erythematosus. II. Role of β2-glycoprotein I. Arthritis Rheum 1998; 40(2): 215-222
28. Rauch J, Subang R, Koh JS, Levine JS. Induction of anti-phospholipid antibodies by β2-glycoprotein I bound to apoptotic thymocytes. Lupus 1998; 7 (Suppl. 1): 66.
29. McIntyre JA. Immune recognition at the maternal-fetal interface: overview. Am J Reprod Immunol 1992; 28: 127-131.
30. La Rosa et al. β2-Glycoprotein I and placental anticoagulant protein I in placentae from patients with anti-phospholipid syndrome J Rheumatol 1994, 21: 1684-1698.
31. Del Papa N et al. Relationship between anti-phospholipid and anti-endothelial antibodies III: β2-glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules. Clin Exp Rheumatol 1995, 13: 179-186.
32. Simantov R et al. Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J Clin Invest 1995; 96: 2211-2219.
33. Le Tonqueze M, Dueymes M, Pterte JC. Is there a role for β2-glycoprotein I in the anti-phospholipid antibody binding to endothelial cells? Lupus 1995, 4. 179-186.
34. Del Papa N et al. Endothelial cells as target for antiphospholipid antibodies human polyclonal and monoclonal anti-β2-glycoprotein I antibodies react in vitro with endothelial cells through adherent β2-glycoprotein I and induce endothelial activation. Arthritis Rheum 1997; 40: 551-562.
35. Del Papa N et al. Endothelial cells as a target for anti-phospholipid antibodies: role of anti-β2-glycoprotein 1 antibodies. Am J Reprod Immunol 1997; 38: 212-217.
36. Del Papa et al. Human β2-glycoprotein I binds to endothelial cells through a cluster of lysine that are critical for anionic phospholipid binding and offers epitopes for anti-β2-glycoprotein I antibodies. J Immunol 1998; 160: 5572-5578.
37. Yan WY, McCrae KR. Beta2-glycoprotein I (β2GPI) binds specifically to human endothelial cells. Lupus 1996; 5: 504 (abstract).
38. Min-Xia W et al. Epitope specificity of monoclonal anti-β2-glycoprotein I antibodies derived from patients with the anti-phospholipid syndrome. J Immunol 1995; 155: 1629-1636.
39. Savage COS, Harper L. Anti-heparin antibodies: part of the repertoire of anti-endothelial cell antibodies (AECA). Lupus 1998; 7: 68-72.
40. Cai G, Satoh T, Hoshi H. Purification and characterization of an endothelial cell-viability maintaining factor from fetal bovine serum. Biochem Biophys Acta 1995, 1269: 195-201
41. Polz F. Isolation of a specific lipid-binding protein from human serum by affinity chromatography using heparin-Sepharose. In Peteis H (ed.) Protides of Biological Fluids. Pergamon Press: Oxford, 1979, p 817
42. Cockwell P, Tse WY, Savage COS. Activation of endothelial cells in thrombosis and vasculitis. Scand J Rheumatol 1997; 26: 145-150.
43. Cronstein BN, Weissman G The adhesion molecules of inflammation. Arthritis Rheum 1993, 36. 147-151.
44. Kaplansky G et al. Increased serum soluble vascular cell adhesion molecule-1 in the antiphospholipid syndrome Lupus 1996; 5: 548 (abstract 182)
45. Beekhuizen H, van Furth R. Monocyte adherence to human vascular endothelium J Leukoc Biol 1993; 54: 363-378.
46. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994; 84: 2068-2101.
47. Lie JT Pathology of the antiphospholipid syndrome In Asherson RA, Cervera R, Piette JC, Shoenfeld Y (eds). The Antiphospholipid Syndrome. CRC Press, Boca Raton, FL 1996, p 89